Transplant for NEMO: this and much, much more
Open Access
- 21 September 2017
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 130 (12) , 1391-1393
Abstract
In this issue of Blood, Miot et al report encouraging results in a retrospective analysis of hematopoietic stem cell transplantation (HSCT) in 29 patients with hypomorphic mutations in the IKBKG gene encoding nuclear factor κB essential modulator (NEMO).1Keywords
This publication has 9 references indexed in Scilit:
- Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutationsBlood, 2017
- Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamideHaematologica, 2016
- Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 DeficiencyTransplantation and Cellular Therapy, 2014
- GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunityBlood, 2014
- Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre studyThe Lancet, 2014
- Novel splicing mutation in the NEMO (IKK‐gamma) gene with severe immunodeficiency and heterogeneity of X‐chromosome inactivationAmerican Journal of Medical Genetics Part A, 2005
- Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiencyBlood, 2004
- X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signalingNature Genetics, 2001
- Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1999